C.Q. Pharmaceutical Holding Co Ltd
C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commerce, warehousing logistics, pharmaceutical industry, and research and development businesses. It also engages in the hospital pure sales, commercial wholesale, retail chain, warehousing logistics, and supply chain value-added services for d… Read more
C.Q. Pharmaceutical Holding Co Ltd (000950) - Total Liabilities
Latest total liabilities as of September 2025: CN¥51.24 Billion CNY
Based on the latest financial reports, C.Q. Pharmaceutical Holding Co Ltd (000950) has total liabilities worth CN¥51.24 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
C.Q. Pharmaceutical Holding Co Ltd - Total Liabilities Trend (1996–2024)
This chart illustrates how C.Q. Pharmaceutical Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
C.Q. Pharmaceutical Holding Co Ltd Competitors by Total Liabilities
The table below lists competitors of C.Q. Pharmaceutical Holding Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CanSino Biologics Inc
PINK:CASBF
|
USA | $2.37 Billion |
|
Shanghai Kaibao Pharmaceutical
SHE:300039
|
China | CN¥412.55 Million |
|
HANOF
PINK:HANOF
|
USA | $221.29 Million |
|
Molson Coors Canada Inc
TO:TPX-B
|
Canada | CA$12.20 Billion |
|
Zhejiang Entive Smart Kitchen Appliance Co. Ltd.
SHE:300911
|
China | CN¥904.95 Million |
|
Nantong Jinghua Pharmaceutical Co Ltd
SHE:002349
|
China | CN¥393.50 Million |
|
Sterlite Technologies Limited
NSE:STLTECH
|
India | ₹37.78 Billion |
Liability Composition Analysis (1996–2024)
This chart breaks down C.Q. Pharmaceutical Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.76 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how C.Q. Pharmaceutical Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for C.Q. Pharmaceutical Holding Co Ltd (1996–2024)
The table below shows the annual total liabilities of C.Q. Pharmaceutical Holding Co Ltd from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥50.17 Billion | +4.48% |
| 2023-12-31 | CN¥48.02 Billion | +7.95% |
| 2022-12-31 | CN¥44.48 Billion | +17.26% |
| 2021-12-31 | CN¥37.93 Billion | +18.72% |
| 2020-12-31 | CN¥31.95 Billion | +92.27% |
| 2019-12-31 | CN¥16.62 Billion | +38.40% |
| 2018-12-31 | CN¥12.01 Billion | +50.98% |
| 2017-12-31 | CN¥7.95 Billion | +80.06% |
| 2016-12-31 | CN¥4.42 Billion | +0.99% |
| 2015-12-31 | CN¥4.37 Billion | -8.04% |
| 2014-12-31 | CN¥4.76 Billion | +15.66% |
| 2013-12-31 | CN¥4.11 Billion | +49.45% |
| 2012-12-31 | CN¥2.75 Billion | +51.79% |
| 2011-12-31 | CN¥1.81 Billion | +5.27% |
| 2010-12-31 | CN¥1.72 Billion | +19.58% |
| 2009-12-31 | CN¥1.44 Billion | -4.41% |
| 2008-12-31 | CN¥1.51 Billion | +225.57% |
| 2007-12-31 | CN¥462.74 Million | -11.38% |
| 2006-12-31 | CN¥522.14 Million | -2.17% |
| 2005-12-31 | CN¥533.73 Million | +6.01% |
| 2004-12-31 | CN¥503.49 Million | -4.27% |
| 2003-12-31 | CN¥525.94 Million | -8.79% |
| 2002-12-31 | CN¥576.60 Million | +0.96% |
| 2001-12-31 | CN¥571.12 Million | +41.36% |
| 2000-12-31 | CN¥404.00 Million | +67.23% |
| 1999-12-31 | CN¥241.59 Million | +7.63% |
| 1998-12-31 | CN¥224.47 Million | +33.72% |
| 1997-12-31 | CN¥167.86 Million | +81.05% |
| 1996-12-31 | CN¥92.72 Million | -- |